In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evofem Biosciences Inc.

www.evofem.com

Latest From Evofem Biosciences Inc.

Keeping Track: Approvals For Phexxi, Kynombi; New Claims For Lynparza, Alunbrig, Tecentriq; Intercept May Miss NASH User Fee Date

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.

US FDA Performance Tracker Approvals

Keeping Track Of Thanksgiving Leftovers: Risdiplam, Artesunate Highlight Glut Of Submissions/Filings

Yes, we know they should be out of the fridge by now, but here are the highlights of submissions and filings during the Thanksgiving week.

US FDA Performance Tracker Drug Review

Evofem Takes Aim At Preventing Pregnancy And STIs With Amphora

Evofem Biosciences is preparing for Phase III trials for Amphora, an on-demand contraceptive that has surpassed Phase II endpoints in preventing bacterial sexually transmitted infections. 

Clinical Trials Infectious Diseases

Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

Evofem intends to refile the NDA for its non-hormonal contraceptive Amphora during the second quarter of 2019, after the Phase III AMPOWER study showed 86% efficacy for typical use and 98.7% efficacy when the gel was used as directed.

Business Strategies Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Alias(es)
  • Instead Healthcare Inc.
  • Evofem Holdings Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Evofem Biosciences Inc.
  • Senior Management
  • Saundra Pelletier, CEO
    Jay File, CFO
    Kelly Culwell, MD, CMO
    Russ Barrons, Chief Commercial Officer
    Tim Glennon, VP, Sales & Mktg.
    Catherine Maher, VP, Reg. Affairs & Quality Assurance
  • Contact Info
  • Evofem Biosciences Inc.
    Phone: (858) 550-1901
    12400 High Bluff Dr.
    Ste. 600
    San Diego, CA 92130
    USA
UsernamePublicRestriction

Register